相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。ALS BIOMARKERS FOR THERAPY DEVELOPMENT: STATE OF THE FIELD AND FUTURE DIRECTIONS
Michael Benatar et al.
MUSCLE & NERVE (2016)
From animal models to human disease: a genetic approach for personalized medicine in ALS
Vincent Picher-Martel et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2016)
Histological Bulbar Manifestations in the ALS Rat
Osama N. Kashlan et al.
NEURODEGENERATIVE DISEASES (2015)
Clinical Trial Designs in Amyotrophic Lateral Sclerosis: Does One Design Fit All?
Katharine A. Nicholson et al.
NEUROTHERAPEUTICS (2015)
A novel SOD1-ALS mutation separates central and peripheral effects of mutant SOD1 toxicity
Peter I. Joyce et al.
HUMAN MOLECULAR GENETICS (2015)
C57BL/6J congenic Prp-TDP43A315T mice develop progressive neurodegeneration in the myenteric plexus of the colon without exhibiting key features of ALS
Theo Hatzipetros et al.
BRAIN RESEARCH (2014)
A phase II-III trial of olesoxime in subjects with amyotrophic lateral sclerosis
T. Lenglet et al.
EUROPEAN JOURNAL OF NEUROLOGY (2014)
Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved?
Hiroshi Mitsumoto et al.
LANCET NEUROLOGY (2014)
GENETIC HETEROGENEITY OF AMYOTROPHIC LATERAL SCLEROSIS: IMPLICATIONS FOR CLINICAL PRACTICE AND RESEARCH
Xiaowei W. Su et al.
MUSCLE & NERVE (2014)
A post hoc analysis of subgroup outcomes and creatinine in the phase III clinical trial (EMPOWER) of dexpramipexole in ALS
Michael E. Bozik et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2014)
Expression of wild-type human superoxide dismutase-1 in mice causes amyotrophic lateral sclerosis
Karin S. Graffmo et al.
HUMAN MOLECULAR GENETICS (2013)
Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insights
Steve Vucic et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial
Merit E. Cudkowicz et al.
LANCET NEUROLOGY (2013)
Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial
LANCET NEUROLOGY (2013)
Design and Initial Results of a Multi-Phase Randomized Trial of Ceftriaxone in Amyotrophic Lateral Sclerosis
James D. Berry et al.
PLOS ONE (2013)
Electrodiagnosis in Persons With Amyotrophic Lateral Sclerosis
Nanette C. Joyce et al.
PM&R (2013)
Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALS
Ettore Beghi et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2013)
Electrical impedance myography as a biomarker to assess ALS progression
Seward B. Rutkove et al.
AMYOTROPHIC LATERAL SCLEROSIS (2012)
CSF markers in amyotrophic lateral sclerosis
Joanna Tarasiuk et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
Lithium lacks effect on survival in amyotrophic lateral sclerosis: a phase IIb randomised sequential trial
Esther Verstraete et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)
Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study
Elisa Majounie et al.
LANCET NEUROLOGY (2012)
A Randomized, Double Blind, Placebo-Controlled Trial of Pioglitazone in Combination with Riluzole in Amyotrophic Lateral Sclerosis
Luc Dupuis et al.
PLOS ONE (2012)
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)
Robert G. Miller et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2012)
Emerging drugs for amyotrophic lateral sclerosis
Ali Aamer Habib et al.
EXPERT OPINION ON EMERGING DRUGS (2011)
Modelling the Effects of Penetrance and Family Size on Rates of Sporadic and Familial Disease
Ammar Al-Chalabi et al.
HUMAN HEREDITY (2011)
Degenerative Myelopathy in a Bernese Mountain Dog with a Novel SOD1 Missense Mutation
F.A. Wininger et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2011)
REPRODUCIBILITY OF MUNIX IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS
Sanjeev D. Nandedkar et al.
MUSCLE & NERVE (2011)
Phase II screening trial of lithium carbonate in amyotrophic lateral sclerosis Examining a more efficient trial design
R. G. Miller et al.
NEUROLOGY (2011)
A phase II trial of talampanel in subjects with amyotrophic lateral sclerosis
Robert M. Pascuzzi et al.
AMYOTROPHIC LATERAL SCLEROSIS (2010)
Guidelines for preclinical animal research in ALS/MND: A consensus meeting
Albert C. Ludolph et al.
AMYOTROPHIC LATERAL SCLEROSIS (2010)
Diagnostic problems and delay of diagnosis in amyotrophic lateral sclerosis
Markus Kraemer et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2010)
Effects of Gender in Amyotrophic Lateral Sclerosis
Pamela A. McCombe et al.
GENDER MEDICINE (2010)
Large-scale SOD1 mutation screening provides evidence for genetic heterogeneity in amyotrophic lateral sclerosis
Michael A. van Es et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial
Swati P. Aggarwal et al.
LANCET NEUROLOGY (2010)
Lithium carbonate in amyotrophic lateral sclerosis Lack of efficacy in a dose-finding trial
A. Chio et al.
NEUROLOGY (2010)
Erythropoietin in amyotrophic lateral sclerosis: A pilot, randomized, double-blind, placebo-controlled study of safety and tolerability
Giuseppe Lauria et al.
AMYOTROPHIC LATERAL SCLEROSIS (2009)
Glatiramer acetate has no impact on disease progression in ALS at 40 mg/day: A double-blind, randomized, multicentre, placebo-controlled trial
Vincent Meininger et al.
AMYOTROPHIC LATERAL SCLEROSIS (2009)
Phase II Trial of CoQ10 for ALS Finds Insufficient Evidence to Justify Phase III
Petra Kaufmann et al.
ANNALS OF NEUROLOGY (2009)
Early Excitability Changes in Lumbar Motoneurons of Transgenic SOD1G85R and SOD1G93A-Low Mice
Arnaud Pambo-Pambo et al.
JOURNAL OF NEUROPHYSIOLOGY (2009)
Biomarkers in amyotrophic lateral sclerosis
Martin R. Turner et al.
LANCET NEUROLOGY (2009)
ELECTRICAL IMPEDANCE MYOGRAPHY: BACKGROUND, CURRENT STATE, AND FUTURE DIRECTIONS
Seward B. Rutkove
MUSCLE & NERVE (2009)
Genome-wide association analysis reveals a SOD1 mutation in canine degenerative myelopathy that resembles amyotrophic lateral sclerosis
Tomoyuki Awano et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Creatine monohydrate in ALS: Effects on strength, fatigue, respiratory status and ALSFRS
Jeffrey Rosenfeld et al.
AMYOTROPHIC LATERAL SCLEROSIS (2008)
Motor unit number estimation in neuromuscular disease
Omid Rashidipour et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2008)
Protein biomarkers for amyotrophic lateral sclerosis
Henrik Ryberg et al.
EXPERT REVIEW OF PROTEOMICS (2008)
Neuron-specific expression of mutant superoxide dismutase is sufficient to induce amyotrophic lateral sclerosis in transgenic mice
Dick Jaarsma et al.
JOURNAL OF NEUROSCIENCE (2008)
Subcutaneous IGF-1 is not beneficial in 2-year ALS trial
E. J. Sorenson et al.
NEUROLOGY (2008)
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial
Paul H. Gordon et al.
LANCET NEUROLOGY (2007)
Electrical impedance myography to assess outcome in amyotrophic lateral sclerosis clinical trials
Seward B. Rutkove et al.
CLINICAL NEUROPHYSIOLOGY (2007)
Phase II/III randomized trial of TCH346 in patients with ALS
R. Miller et al.
NEUROLOGY (2007)
Bayesian statistical mune method
Robert D. Henderson et al.
MUSCLE & NERVE (2007)
Good practice in the management of amyotrophic lateral sclerosis: Clinical guidelines. An evidence-based review with good practice points. EALSC Working Group
Peter Munch Andersen et al.
AMYOTROPHIC LATERAL SCLEROSIS (2007)
Glatiramer acetate immunization induces specific antibody and cytokine responses in ALS patients
R. Lee Mosley et al.
AMYOTROPHIC LATERAL SCLEROSIS (2007)
Predictors of delay in the diagnosis and clinical trial entry of amyotrophic lateral sclerosis patients: A population-based study
Stefano Zoccolella et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
Motor neuron disease in mice expressing the wild type-like D90A mutant superoxide dismutase-1
P. Andreas Jonsson et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
Trial of celecoxib in amyotrophic lateral sclerosis
Merit E. Cudkowicz et al.
ANNALS OF NEUROLOGY (2006)
Pentoxifylline in ALS: A double-blind, randomized, multicenter, placebo-controlled trial
B Levin et al.
NEUROLOGY (2006)
Test-retest reproducibility of 50 kHz linear-electrical impedance myography
SB Rutkove et al.
CLINICAL NEUROPHYSIOLOGY (2006)
Analysis of reasons for the late diagnosis of amylotrophic lateral sclerosis.
F. Torny et al.
REVUE NEUROLOGIQUE (2006)
Altered axonal excitability properties in amyotrophic lateral sclerosis: impaired potassium channel function related to disease stage
K Kanai et al.
BRAIN (2006)
Diagnostic investigation and multidisciplinary management in motor neuron disease
JA Rocha et al.
JOURNAL OF NEUROLOGY (2005)
High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study
M Graf et al.
JOURNAL OF NEURAL TRANSMISSION (2005)
Efficacy and safety of xaliproden in amyotrophic lateral sclerosis: results of two phase III trials
V Meininger et al.
AMYOTROPHIC LATERAL SCLEROSIS (2004)
The use of statistical mune in a multicenter clinical trial
JM Shefner et al.
MUSCLE & NERVE (2004)
Motor unit number estimation in human neurological diseases and animal models
JM Shefner
CLINICAL NEUROPHYSIOLOGY (2001)
El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis
BR Brooks et al.
AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS (2000)
Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1
D Jaarsma et al.
NEUROBIOLOGY OF DISEASE (2000)
Shortening the time to the diagnosis of amyotrophic lateral sclerosis: role of the neurologist
AL Dubrovsky
AMYOTROPHIC LATERAL SCLEROSIS (2000)
分享论文
